FindTrial
Sign In

This is a study to evaluate non-invasive procedures for patients diagnosed as Central Serous Chorioretinopathy

Correlation on Fluorescein Angiography, High Resolution Spectral Domain Optical Coherence Tomography with Enhanced Depth Imaging and Autoflourescence in Central Serous Retinopathy.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/04/013205
Enrollment
100
Registered
2018-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NIL: NIL

Sponsors

Giridhar Eye Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All cases acute or chronic with active Central Serous Chorioretinopathy

Exclusion criteria

Exclusion criteria: Patients with polipoidal choroidal vasculopathy, age related macular diseases and any other inflammatory pathology.

Design outcomes

Primary

MeasureTime frame
To report the exact location of multiple yellowish dot-like precipitates in Central Serous Chorioretinopathy.Timepoint: To report the exact location of multiple yellowish dot-like precipitates in Central Serous Chorioretinopathy.—

Secondary

MeasureTime frame
A detailed protocol will be used to obtain significant history to assess various risk factors contributing to CSC affected eye recorded by Enhanced Depth Imaging Optical Coherence Tomography.Timepoint: 12 Months—

Countries

India

Contacts

Public ContactDr Mahesh G

Giridhar Eye Institute

maheshgopalakrishnan@yahoo.com9388467893

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026